Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion

Osteoporosis International

Volumn 9, Issue 5, 1999, Pages 449-454

  Del Campo, M T ^a   Gonzalez Casaus M L ^b   Aguado, P ^a   Bernad, M ^a   Carrera, F ^a   Martinez M E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

Author keywords

Deoxypyridinoline; Menopause; Osteoporosis; Pyridinium crosslinks; Pyridinoline; Telopeptides

Indexed keywords

DEOXYPYRIDINOLINE; PYRIDINIUM DERIVATIVE;

ADULT; AGE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CROSS LINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MENOPAUSE; NORMAL HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; URINARY EXCRETION;

ADULT; AGED; AGING; AMINO ACIDS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMILUMINESCENT MEASUREMENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOASSAY; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; PYRIDINIUM COMPOUNDS;

EID: 0345535717     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050170     Document Type: Article

References (22)

1. Eastell R, Colwell A, Hampton L, et al. Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis. J Bone Miner Res 1997;12:59-65.
2. Delmas PD, Schlemmer A, Gineyts E, et al. Urinary excretion of pyridinoline correlates with bone turn-over measured on iliac crest biopsy. J Bone Miner Res 1991;6:639-44.
3. Uebelhart D, Gineyts E, Delmas PD. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic disease. Bone Miner 1990;8:87-96.
4. Seibel MJ, Cosman F, Shen V, et al. Urinary hydroxy pyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993;8:881-9.
5. Delmas PD, Gineyts E, Bertholin A, et al. Immunoassay of pyridinoline excretion in normal adults and Paget's disease. J Bone Miner Res 1993;8:643-648.
6. Garnero P, Shih WJ, Gineyts E, et al. Comparison of new biochemical markers of bone turnover in late postmenopausal women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693-700.
7. Melton III LJ, Khosla S, Atkinson EJ, et al. Relationship of bone turnover to bone density and fractures, J Bone Miner Res 1997;12:1083-91.
8. Robins S, Duncan A, Wilson N, et al. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation. Clin Chem 1996;42:1621-6.
9. Hanson DA, Eyre DR. A specific immunoassay for bone resorption based on crosslinked collagen peptides in urine. J Bone Miner Res 1991;6:669a.
10. Seyedin SM, Kung VT, Daniloff YN, et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993;8:635-41.
11. Gómez B Jr, Ardakani S, Evans BJ, et al. Monoclonal antibody assay for free urinary pyridinium crosslinks. Clin Chem 1996;42:1168-75.
12. Garnero P, Gineyts E, Arbault P, et al. Different effects of bisphosphonate and oestrogen therapy on peptide-bound bone crosslink excretion. J Bone Miner Res 1995;10:641-49.
13. Blumsohn A, Naylor K, Assiri A, et al. Different responses of biochemical markers of bone resorption to bisphosphonate therapy in Paget's disease. Clin Chem 1995;41:1592-8.
14. Ebeling PR, Atley LM, Guthrie JR, et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996;81:3366-71.
15. Kamel S, Brazier M, Rogez JC, et al. Different responses of free and peptide-bound crosslinks to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency. J Clin Endocrinol Metab 1996;81:3717-21.
16. Tobias JH, Laversuch CU, Wilson N, et al. Neridronate preferentially suppresses the urinary excretion of peptide-bound deoxypyridinoline in postmenopausal women. Calcif Tissue Int 1996;59:407-9.
17. Vinholes J, Guo CY, Purohit OP, et al. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. J Clin Oncol 1997;15:131-8.
18. Stockham Hannon SW, Naylor KE, Henry YM, et al. Use of T-scores to relate levels of biochemical markers of bone turn-over to premenopausal reference intervals. J Bone Miner Res 1997; Suppl:177.
19. Fradinger EE, Volta SM, Salica D, et al. Performance of urinary markers of bone resorption expressed as T-score. J Bone Miner Res 1997;Suppl:588.
20. Kamel S, Brazier M, Meri V, et al. Multiple molecular forms of pyridinoline crosslinks excreted in human urine evaluated by chromatographic and immunoassay methods. J Bone Miner Res 1995;10:1385-92.
21. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series. Geneve: WHO, 1993.
22. Russell RGG. The assessment of bone metabolism in vivo using biochemical approaches. Horm Metab Res 1997;29:138-44.